GlassScriptPhysician profile
Kenneth Joel Bloom
NPI 1023399177
$79,550.00
in general payments reported to CMS, 2019-2025
9 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Anatomic Pathology providers received nationally (typical 2025 total: $110).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $13K · 2021: $4,558 · 2022: $3,034 · 2023: $4,368 · 2024: $108 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $1,733 · Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,212.50 |
| Travel and Lodging | $1,733.30 |
| Food and Beverage | $817.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ventana Medical Systems, INC. | $22,636.22 | 2019-2022 | |
| Daiichi Sankyo INC. | $22,322.19 | 2019-2025 | Enhertu |
| Merck Sharp & Dohme LLC | $10,534.99 | 2019-2020 | |
| F. Hoffmann-La Roche Ag | $7,746.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $7,097.15 | 2020-2025 | Enhertu |
| Agilent Technologies, INC. | $5,502.34 | 2020-2023 | |
| Mirati Therapeutics, INC. | $2,078.70 | 2023 | Krazati |
| Regeneron Healthcare Solutions, INC. | $1,557.50 | 2021 | |
| Kyowa Kirin, INC. | $74.47 | 2022-2023 | Poteligeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.